全球胸廓出口综合征市场 - 行业趋势和 2029 年预测

市场分析和见解全球胸廓出口综合征市场

预计胸廓出口综合征市场将在 2022-2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在上述预测期内，市场复合年增长率将达到 5.30%。

胸廓出口综合征 (TOC) 是一组导致手指麻木和刺痛以及颈部、肩部和手臂疼痛的疾病。胸廓出口（锁骨和第一肋骨之间的区域）的血管和神经受到压迫会导致胸廓出口综合征。肩部或颈部损伤、解剖异常、体育活动事故、肥胖和胸部肿瘤都是胸廓出口综合征的典型原因。血管性、神经性和非特异性胸廓出口综合征是胸廓出口综合征的三种形式。治疗药物（例如抗炎药、抗凝药和肌肉松弛剂）用于治疗胸廓出口综合征。当药物治疗无法缓解胸廓出口综合征的症状时，可使用手术来缓解疼痛。

The rise in the prevalence of thoracic outlet syndrome is the major driver resulting in the expansion of market’s growth. Another significant factor influencing the growth rate of thoracic outlet syndrome market is the rising healthcare expenditure. Furthermore, advancement in the medical technology, growing government funding and rising initiatives by public and private organisations to spread awareness are the factors that will expand the thoracic outlet syndrome market. Other factors such as increase in the level of disposable income and growing cases of anatomical defects will positively impact the thoracic outlet syndrome market’s growth rate. Additionally, improvements associated with reimbursement policies will result in the expansion of thoracic outlet syndrome market.

Moreover, the rise in the research and development activities and high unmet need of current treatment will provide beneficial opportunities for the thoracic outlet syndrome market in the forecast period of 2022-2029. Also, developments in the healthcare technology will escalate the growth rate thoracic outlet syndrome market in future.

However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of thoracic outlet syndrome market. Additionally, complications involved with thoracic outlet syndrome will hinder the thoracic outlet syndrome market growth. Less awareness about thoracic outlet syndrome will further challenge the market in the forecast period mentioned above.

This thoracic outlet syndrome market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the thoracic outlet syndrome market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Thoracic Outlet Syndrome Market Scope and Market Size

The thoracic outlet syndrome market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the thoracic outlet syndrome market is segmented into neurogenic thoracic outlet syndrome, venous thoracic outlet syndrome, and arterial thoracic outlet syndrome.
• On the basis of treatment, the thoracic outlet syndrome market is segmented into surgery, medications, physical therapy and others. The medication segment is further sub-segmented into non-steroidal anti-inflammatory drugs (NSAID), skeletal muscle relaxants, anticoagulants, and botulinum toxin therapeutics.
• On the basis of diagnosis, the thoracic outlet syndrome market is segmented into nerve conduction studies, vascular studies, chest X-ray, cervical spine X-rays, computed tomography (CT) scan, magnetic resonance imaging (MRI), magnetic resonance imaging with angiography (MRA), arteriogram/venogram, and blood tests.
• On the basis of dosage, the thoracic outlet syndrome market is segmented into injection, tablets and others.
• On the basis of route of administration, the thoracic outlet syndrome market is segmented into oral, parenteral and others.
• On the basis of end-users, the thoracic outlet syndrome market is segmented into clinic, hospital and others.

The thoracic outlet syndrome market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Thoracic Outlet Syndrome Market Country Level Analysis

Thoracic outlet syndrome market is analyzed and market size information is provided by the country, type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the thoracic outlet syndrome market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the thoracic outlet syndrome market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector, and growing government support.

报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。

患者流行病学分析

胸廓出口综合征市场还为您提供详细的市场分析，以进行患者分析、预后和治疗。患病率、发病率、死亡率、依从率是报告中提供的一些数据变量。分析流行病学对市场增长的直接或间接影响，以创建更稳健、更队列的多元统计模型，用于预测增长期的市场。

竞争格局和全球胸廓出口综合征市场份额分析

胸廓出口综合征市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对胸廓出口综合征市场研究的关注有关。

胸廓出口综合征市场的一些主要参与者包括 Piramal Critical Care、Validus Pharmaceuticals LLC、辉瑞公司、葛兰素史克公司、诺华公司、赛诺菲、雅培、拜耳公司、百时美施贵宝公司、F. Hoffmann-La Roche Ltd.、Mallinckrodt、强生私人有限公司、Endo International plc、勃林格殷格翰国际有限公司、Apotex Inc.、Mylan NV、Allergan、武田制药有限公司、东方制药和第一三共有限公司等。

SKU-67506